Top 5 Infectious Disease Stories Week of March 23

News
Article

FDA authorizes Ito Invivyd’s pemivibart (Pemgarda), insights on Sofosbuvir levels in pregnant women, the effectiveness of fidaxomicin vs vancomycin for CDI treatment, and more this week from Contagion.

Recent Videos
A panel of 5 experts on C. difficile infections
A panel of 5 experts on C. difficile infections
Related Content
New Genomic Study Reveals Hidden Pathways of C difficile Transmission in Hospitals

New Genomic Study Reveals Hidden Pathways of C difficile Transmission in Hospitals

Sophia Abene
April 4th 2025
Article
C difficile, Antimicrobials, and the Patients Most Affected

C difficile, Antimicrobials, and the Patients Most Affected

Nina Cosdon
November 23rd 2022
Podcast
New Meta-Analysis Highlights Most Effective Treatments for Clostridioides difficile Infection

New Meta-Analysis Highlights Most Effective Treatments for Clostridioides difficile Infection

Sophia Abene
February 6th 2025
Article
Investigational Live Biotherapeutic Product Significantly Reduces Risk of Recurrent Clostridioides difficile

Investigational Live Biotherapeutic Product Significantly Reduces Risk of Recurrent Clostridioides difficile

Contagion Editorial Team
January 24th 2025
Article
LPOXY Therapeutics Acquires Assets to Advance C difficile Protection for Antibiotic Patients

LPOXY Therapeutics Acquires Assets to Advance C difficile Protection for Antibiotic Patients

Sophia Abene
January 8th 2025
Article
Contagion's 2024 Top Stories: C difficile

Contagion's 2024 Top Stories: C difficile

Contagion Editorial Team
December 28th 2024
Article
© 2025 MJH Life Sciences

All rights reserved.